Adaptimmune Therapeutics (ADAP)
(Delayed Data from NSDQ)
$1.08 USD
+0.02 (1.42%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.08 +0.01 (0.47%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMKey Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/10/2024
Time: -- |
3/2024 | $-0.16 | 6.25% |
Earnings Summary
For their last quarter, Adaptimmune Therapeutics (ADAP) reported earnings of -$0.24 per share, missing the Zacks Consensus Estimate of -$0.12 per share. This reflects a negative earnings surprise of 100.00%. Look out for ADAP's next earnings release expected on May 10, 2024. For the next earning release, we expect the company to report earnings of -$0.16 per share, reflecting a year-over-year decrease of 1700%.
Earnings History
Price & Consensus
Zacks News for ADAP
Adaptimmune Therapeutics PLC (ADAP) Stock Moves -1.24%: What You Should Know
ADAP: What are Zacks experts saying now?
Zacks Private Portfolio Services